Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
660.00    -5.00 (-0.75%)
Bid:
660.00
Ask:
663.00
Spread: 3.00 (0.455%)
Market Cap: £537.21m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Director/PDMR Shareholding

8 Dec 2025 10:05

RNS Number : 6484K
Bloomsbury Publishing PLC
08 December 2025
 

08 December 2025

 

Bloomsbury Publishing Plc (the "Company")

 

Director/PDMR Shareholdings

 

The Company was made aware today that, as part of a dividend reinvestment plan, John Bason, the Company's Non-executive Chairman, purchased 90 ordinary shares of £0.0125 ("Ordinary Shares") on the market at a price of 496.84 pence per Ordinary Share on 28 November 2025. Following this transaction, he (including persons closely associated with him) holds a total of 23,109 shares in the Company, representing approximately 0.03% of the current Issued Share Capital of the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation), which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

John Bason

2

Reason for the notification

a)

Position/status

Non-executive Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Share purchase

 

c)

Price(s) and volume(s)

Price

No. of shares

£4.9684

90

d)

Aggregated information

 

e)

Date of the transaction

28 November 2025

f)

Place of the transaction

AQSE Trading (Equity)

 

 

 For further information, please contact:

Bloomsbury Publishing Plc

Maya Abu-Deeb, Group General Counsel & Company Secretary

maya.abu-deeb@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder / Hattie Dreyfus / Emily Brooker

bloomsbury@hudsonsandler.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGBDDDGGDGUI
Date   Source Headline
1st Jun 20185:03 pmRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSFinal Results
18th May 20183:23 pmRNSBlock Listing Six Monthly Return
8th May 20187:00 amRNSBloomsbury and Spotify announce partnership
1st May 20186:25 pmRNSAcquisition of IB Tauris & Co. Limited
1st May 20187:00 amRNSAcquisition of IBT Tauris & Co. Limited
19th Apr 20187:00 amRNSBoard Appointment
19th Mar 20184:37 pmRNSTrading Update
21st Dec 20177:00 amRNSDirectorate Change
17th Nov 201711:44 amRNSBlock listing Interim Review
2nd Nov 201712:25 pmRNSHolding(s) in Company
24th Oct 20177:00 amRNSHalf-year Report
2nd Oct 20173:22 pmRNSHolding(s) in Company
22nd Sep 20177:00 amRNSInterim Results Date Change
5th Sep 20174:57 pmRNSDirector/PDMR Shareholding
11th Aug 20172:24 pmRNSDirector/PDMR Shareholding
28th Jul 201712:56 pmRNSDirector/PDMR Shareholding
28th Jul 201712:54 pmRNSDirector/PDMR Shareholding
28th Jul 201712:54 pmRNSDirector/PDMR Shareholding
28th Jul 201712:52 pmRNSDirector/PDMR Shareholding
20th Jul 20177:00 amRNSDirector/PDMR Shareholding
18th Jul 20171:19 pmRNSResults of voting on resolutions at the AGM
18th Jul 20177:00 amRNSTrading Statement
4th Jul 20172:45 pmRNSDirector/PDMR Shareholding
19th Jun 20179:55 amRNSAnnual Financial Report
16th Jun 20177:00 amRNSBoard Appointment
19th May 20174:44 pmRNS6 Month Blocklisting Return
18th May 20177:00 amRNSFinal Results
23rd Mar 20171:47 pmRNSHolding(s) in Company
20th Jan 20177:00 amRNSBoard Appointment
4th Jan 20177:15 amRNSEmployee Benefit Trust purchase of shares
13th Dec 20164:53 pmRNSDirector/PDMR Shareholding
13th Dec 20164:52 pmRNSDirector/PDMR Shareholding
13th Dec 20164:50 pmRNSDirector/PDMR Shareholding
13th Dec 20164:46 pmRNSDirector/PDMR Shareholding
18th Nov 201610:35 amRNSBlock Listing Six Monthly Return
1st Nov 20164:08 pmRNSHolding(s) in Company
1st Nov 20162:58 pmRNSHolding(s) in Company
27th Oct 20167:00 amRNSHalf-year Report
4th Oct 20164:35 pmRNSPrice Monitoring Extension
12th Sep 20164:30 pmRNSPro forma historic results
31st Aug 20163:09 pmRNSTotal Voting Rights
23rd Aug 20162:14 pmRNSApplication for Admission
16th Aug 20169:55 amRNSHolding(s) in Company
19th Jul 20161:24 pmRNSResults of voting on resolutions at the AGM
18th Jul 20163:15 pmRNSHolding(s) in Company
13th Jul 20167:00 amRNSCapital Markets Day and Business Update
4th Jul 20165:31 pmRNSHolding(s) in Company
24th Jun 20162:43 pmRNSAnnual Financial Report
9th Jun 201612:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.